Cargando…
Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]
The mRNA vaccines from Pfizer/BioNTech and Moderna were granted emergency approval in record time in the history of vaccinology and played an instrumental role in limiting the pandemic caused by SARS-CoV-2. The success of these vaccines resulted from over 3 decades of research from many scientists....
Autores principales: | Jawalagatti, Vijayakumar, Kirthika, Perumalraja, Lee, John Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110646/ https://www.ncbi.nlm.nih.gov/pubmed/35592330 http://dx.doi.org/10.3389/fimmu.2022.884862 |
Ejemplares similares
-
A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022) -
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022) -
Evaluation of host and bacterial gene modulation during Lawsonia intracellularis infection in immunocompetent C57BL/6 mouse model
por: Kirthika, Perumalraja, et al.
Publicado: (2022) -
Targeting primary and metastatic tumor growth in an aggressive breast cancer by engineered tryptophan auxotrophic Salmonella Typhimurium
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022) -
Structure, Substrate Specificity and Role of Lon Protease in Bacterial Pathogenesis and Survival
por: Kirthika, Perumalraja, et al.
Publicado: (2023)